These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9858069)

  • 21. The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum.
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 May; 92(1):45-54. PubMed ID: 16488021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical differences between early and late remission in depressive patients.
    Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
    J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
    Tohen M; Zarate CA; Hennen J; Khalsa HM; Strakowski SM; Gebre-Medhin P; Salvatore P; Baldessarini RJ
    Am J Psychiatry; 2003 Dec; 160(12):2099-107. PubMed ID: 14638578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression.
    Kim KH; Lee SM; Paik JW; Kim NS
    J Affect Disord; 2011 Jul; 132(1-2):121-9. PubMed ID: 21402412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The naturalistic course of unipolar major depression in the absence of somatic therapy.
    Posternak MA; Solomon DA; Leon AC; Mueller TI; Shea MT; Endicott J; Keller MB
    J Nerv Ment Dis; 2006 May; 194(5):324-9. PubMed ID: 16699380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.
    Nierenberg AA; Petersen TJ; Alpert JE
    J Clin Psychiatry; 2003; 64 Suppl 15():13-7. PubMed ID: 14658986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study.
    Mazzarini L; Kotzalidis GD; Piacentino D; Rizzato S; Angst J; Azorin JM; Bowden CL; Mosolov S; Young AH; Vieta E; Girardi P; Perugi G;
    J Affect Disord; 2018 Mar; 229():164-170. PubMed ID: 29310066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.
    Judd LL; Akiskal HS
    Pharmacopsychiatry; 2000 Jan; 33(1):3-7. PubMed ID: 10721877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
    Solomon DA; Keller MB; Leon AC; Mueller TI; Shea MT; Warshaw M; Maser JD; Coryell W; Endicott J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1001-6. PubMed ID: 9366656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from a recurrent major depressive episode.
    Kravitz HM; Bloom RW; Fawcett J
    Depress Anxiety; 2000; 12(1):40-3. PubMed ID: 10999244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder.
    Judd LL; Akiskal HS; Paulus MP
    J Affect Disord; 1997 Aug; 45(1-2):5-17; discussion 17-8. PubMed ID: 9268771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple recurrences of major depressive disorder.
    Solomon DA; Keller MB; Leon AC; Mueller TI; Lavori PW; Shea MT; Coryell W; Warshaw M; Turvey C; Maser JD; Endicott J
    Am J Psychiatry; 2000 Feb; 157(2):229-33. PubMed ID: 10671391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients.
    Xiao L; Zhou JJ; Feng Y; Zhu XQ; Wu WY; Hu YD; Niu YJ; Hu J; Wang XY; Gao CG; Zhang N; Fang YR; Liu TB; Jia FJ; Feng L; Wang G
    Asian J Psychiatr; 2020 Jan; 47():101843. PubMed ID: 31731143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive reactivity versus dysfunctional cognitions and the prediction of relapse in recurrent major depressive disorder.
    Figueroa CA; Ruhé HG; Koeter MW; Spinhoven P; Van der Does W; Bockting CL; Schene AH
    J Clin Psychiatry; 2015 Oct; 76(10):e1306-12. PubMed ID: 26528654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
    Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
    Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS).
    Jang S; Jung S; Pae C; Kimberly BP; Craig Nelson J; Patkar AA
    J Affect Disord; 2013 Dec; 151(3):854-9. PubMed ID: 24021959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F; Akiskal H
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term natural history of the weekly symptomatic status of bipolar I disorder.
    Judd LL; Akiskal HS; Schettler PJ; Endicott J; Maser J; Solomon DA; Leon AC; Rice JA; Keller MB
    Arch Gen Psychiatry; 2002 Jun; 59(6):530-7. PubMed ID: 12044195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.